SGEN : Summary for Seattle Genetics, Inc. - Yahoo Finance

U.S. Markets closed

Seattle Genetics, Inc. (SGEN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
68.26+1.33 (+1.99%)
At close: 4:00PM EDT

68.30 0.04 (0.06%)
After hours: 5:40PM EDT

People also watch
IMGNBMRNINCYALNYCLDX
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close66.93
Open67.25
Bid68.26 x 1000
Ask70.48 x 100
Day's Range66.61 - 68.68
52 Week Range32.40 - 75.36
Volume408,469
Avg. Volume763,145
Market Cap9.74B
Beta2.52
PE Ratio (TTM)-68.60
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Associated Press3 hours ago

    Seattle Genetics reports 1Q loss

    On a per-share basis, the Bothell, Washington-based company said it had a loss of 42 cents. The results missed Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment ...

  • Business Wire3 hours ago

    Seattle Genetics Reports First Quarter 2017 Financial Results

    Seattle Genetics, Inc. , a global biotechnology company, today reported financial results for the first quarter ended March 31, 2017. The company also highlighted ADCETRIS commercialization and clinical development accomplishments, vadastuximab talirine and enfortumab vedotin activities, as well as progress with its pipeline of antibody-drug conjugates and other proprietary programs.

  • Accesswire7 hours ago

    Investor Network: Seattle Genetics, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / April 27, 2017 / Seattle Genetics, Inc. (NASDAQ: SGEN) will be discussing their earnings results in their Q1 Earnings Call to be held April 27, 2017 at 4:30 PM Eastern Time. ...